ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41,723	63,405	50,097	50,201	39,203	38,625
Short-Term Investments	2,278	9,518	40,000	-	44,000	84,001
Trading Asset Securities	45,128	48,001	-	-	10,013	18,011
Cash & Short-Term Investments	89,129	120,924	90,097	50,201	93,216	140,636
Cash Growth	-19.20%	34.22%	79.47%	-46.15%	-33.72%	116.23%
Accounts Receivable	57,514	67,846	120,566	94,210	62,949	45,435
Other Receivables	-	1,972	1,500	3,131	1,499	1,236
Receivables	57,514	69,817	122,066	97,341	64,448	46,671
Inventory	163,128	126,963	120,736	107,623	80,809	45,401
Prepaid Expenses	10,204	9,120	11,901	5,818	5,039	1,798
Other Current Assets	2,513	3,254	3,577	2,251	628.76	1,107
Total Current Assets	322,490	330,078	348,378	263,234	244,142	235,613
Property, Plant & Equipment	361,259	338,695	280,105	257,885	210,190	175,634
Long-Term Investments	7,203	8,913	10,728	11,492	13,264	7,756
Goodwill	-	10,599	9,950	8,947	8,455	8,044
Other Intangible Assets	16,703	5,933	3,513	3,532	4,164	1,952
Long-Term Deferred Tax Assets	6,276	7,352	7,498	17,127	15,732	14,699
Other Long-Term Assets	18,461	20,305	15,264	8,436	2,619	1,872
Total Assets	732,392	721,876	675,436	570,652	498,565	445,570
Accounts Payable	16,974	10,646	17,661	18,095	12,865	4,694
Accrued Expenses	-	4,566	8,264	9,365	6,558	3,097
Short-Term Debt	65,499	30,000	20,878	105,854	-	-
Current Portion of Long-Term Debt	4,167	42,217	8,333	8,293	15,000	-
Current Portion of Leases	1,585	1,158	1,039	1,185	587.24	894.1
Current Income Taxes Payable	1,101	7,115	4,430	2,377	1,322	-
Current Unearned Revenue	-	6,818	2,391	-	-	-
Other Current Liabilities	58,272	30,761	20,748	34,054	16,243	9,925
Total Current Liabilities	147,596	133,281	83,745	179,224	52,575	18,610
Long-Term Debt	45,502	43,255	159,689	16,707	91,451	125,646
Long-Term Leases	1,544	1,512	2,143	2,481	479.1	386.54
Long-Term Unearned Revenue	-	2,738	2,791	-	956.3	1,698
Other Long-Term Liabilities	36,473	37,333	39,578	31,138	27,071	2,451
Total Liabilities	231,941	218,885	288,530	229,549	172,533	148,817
Common Stock	10,076	10,076	9,404	9,404	9,404	9,328
Additional Paid-In Capital	315,593	315,593	225,940	195,747	195,714	174,919
Retained Earnings	155,993	159,437	135,729	126,893	115,590	111,634
Comprehensive Income & Other	19,349	18,025	13,476	5,587	2,266	-552.72
Total Common Equity	501,012	503,132	384,550	337,632	322,974	295,328
Minority Interest	-561.15	-141.19	2,356	3,471	3,058	1,425
Shareholders' Equity	500,451	502,991	386,906	341,103	326,033	296,753
Total Liabilities & Equity	732,392	721,876	675,436	570,652	498,565	445,570
Total Debt	118,296	118,142	192,082	134,521	107,517	126,927
Net Cash (Debt)	-29,167	2,782	-101,984	-84,320	-14,301	13,709
Net Cash Growth	-	-	-	-	-	-72.05%
Net Cash Per Share	-1449.54	142.64	-5422.17	-4483.00	-766.21	734.85
Filing Date Shares Outstanding	20.15	20.15	18.81	18.81	18.81	18.66
Total Common Shares Outstanding	20.15	20.15	18.81	18.81	18.81	18.66
Working Capital	174,893	196,797	264,634	84,010	191,567	217,003
Book Value Per Share	24860.55	24965.77	20445.26	17950.76	17171.46	15830.19
Tangible Book Value	484,309	486,600	371,088	325,153	310,355	285,333
Tangible Book Value Per Share	24031.74	24145.44	19729.50	17287.30	16500.56	15294.42
Land	-	60,200	60,024	59,999	52,910	52,908
Buildings	-	149,266	146,984	118,168	102,362	103,273
Machinery	-	203,768	195,642	157,855	120,141	115,304
Construction In Progress	-	93,149	20,794	44,421	50,144	12,071

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.